Vaccination 
- Posted under:
- News
GSK to lower prices to woo India mkt
CEO Says Pharma Major Plans To Invest Rs 430 Cr To Develop Vaccines Here
GLAXOSMITHKLINE (GSK) would cut retail prices in India to cater to the lower-income segment besides pumping in Rs 430 crore to develop vaccines from its local facilities, according to Andrew Witty, global CEO of the world’s second-largest drugmaker.
- Date:
- 10/03/2010
- Source:
- Economic Times (New Delhi)
Tags
- Posted under:
- News
Desi swine flu vaccine ready for commercial use by April-May
New Delhi:Pune-based Serum India’s swine flu vaccine ‘Fluvac’ will be ready for commercial use by April-May, subject to all regulatory clearances. The Pune-based company received the drug regulators go-ahead on March 5 to carry out advanced safety tests on the vaccine —Phase II/III clinical trials crucial for its introduction in the market.
- Date:
- 09/03/2010
- Source:
- Times Of India (New Delhi)
Tags
- Posted under:
- News
Public health issues: need for more media concern
Wisdom has dawned at long last on the public health establishment of the country.
- Date:
- 08/03/2010
- Source:
- Hindu (New Delhi)
Tags
- Posted under:
- News
H1N1 vaccine: Phases II, III human trials begin today
Pune Four centres to take part, two in city
The Serum Institute of India will begin phase II and III human clinical trials
of the nasal spray vaccine against the H1N1 virus at two sites in Pune and three other centres on Monday. The virus has claimed 201 lives in Pune itself.
- Date:
- 08/03/2010
- Source:
- Indian Express (Mumbai)
Tags
- Posted under:
- News
Indian vaccine to be out mid-May
New Delhi: The country’s first indigenously produced vaccine against H1N1 virus will be ready for use from mid-May. The vaccine produced by Ahmedabad based Zydus Cadila may be rolled out first, followed closely by others like Serum Institute and Panacea Biotec.
- Date:
- 04/03/2010
- Source:
- Times Of India (New Delhi)
Tags
- Posted under:
- News
H1N1 shots from next week
Imported Vaccines Have Passed Safety Test
New Delhi: Mass vaccination against the deadly H1N1 swine flu virus are likely to begin in India next week. The 1.5 million doses of vaccines imported by the government from Sanofi Pasteur have passed the safety test.
- Date:
- 04/03/2010
- Source:
- Times Of India (New Delhi)
Tags
- Posted under:
- News
Influenza vaccine in a month
Azad asks young doctors to opt for postings in rural areas
The vaccine has reached the human clinical trial stage
68 students receive degrees at NIMHANS convocation
Bangalore:An indigenously developed vaccine against influenza could be a month away, according to Union Minister of Health and Family Welfare Ghulam Nabi Azad.
- Date:
- 04/03/2010
- Source:
- Hindu (New Delhi)
Tags
- Posted under:
- News
Govt go-ahead to 3 suspended labs for vaccine production
New Delhi: Vaccine production will resume at three of India’s oldest vaccine manufacturing units.
In a major turnaround, the Union health ministry on February 26 gave the three units — BCG Vaccine Laboratory (Chennai), Pasteur Institute of India (Coonoor) and the Central Research Institute (Kasauli) — a full fledged go ahead to start manufacturing vaccines once again.
- Date:
- 03/03/2010
- Source:
- Times Of India (New Delhi)
Tags
- Posted under:
- Feature Articles
High hopes for oral cholera vaccine
A trial of a new oral cholera vaccine in Kolkata is promising but, as Patralekha Chatterjee reports, a vaccine is only one weapon
in the battle against the disease.
- Date:
- Mar 2010
- Source:
- Bulletin of the World Health Organization Vol: 88 Issue: 3 pp: 165-166
Tags
- Posted under:
- News
Now, store vaccines even at room temp
Scientists may have finally found a way to deal with one of the developing world’s worst problems in healthcare — faulty and inadequate cold chain for vaccine storage. British scientists from Oxford University have found a way to keep vaccines stable even at room temperature.
- Date:
- 19/02/2010
- Source:
- Times Of India (New Delhi)
